KERSHAW HEALTH — History
CCN 420048 | 3-year financial timeline | COVID resilience: 26/100
🛡️ Public data only — no PHI permitted on this instance.
$85M
Latest Revenue (FY2022)
-8.1%
Revenue CAGR (3yr)
-19.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $101M | $92M | $85M | -7.5% | -8.1% |
| Operating Expenses | $110M | $95M | $101M | +6.4% | -4.0% |
| Operating Margin | -9.2% | -3.7% | -19.3% | -424.8% | +0.0% |
| Net Income | $-9M | $-3M | $-16M | -385.3% | +0.0% |
| Licensed Beds | 94 | 90 | 99 | +10.0% | +2.6% |
| Total Patient Days | 14,454 | 12,428 | 13,959 | +12.3% | -1.7% |
| Medicare Day % | 36% | 37% | 34% | -8.1% | -3.4% |
| Medicaid Day % | 6% | 2% | 7% | +196.3% | +8.6% |
COVID Impact & Recovery
Resilience Score: 26/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -15.6% ($101M → $85M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-8.1%
This Hospital
+7.6%
State Avg
Latest Margin
-19.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $77M | -24.3% |
| FY2024 (proj) | $69M | -29.4% |
| FY2025 (proj) | $61M | -34.4% |